findmyKOL
Clinical trialNCT04565509CompletedInterventional

Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic

SponsorWashington University School of MedicineEnrollment1,143Child Development DisorderCovid19Developmental DisabilityIntellectual Disability
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary goal of this project is to identify the best messaging and implementation strategies to maximize SARS-CoV-2 testing for children with intellectual and developmental disabilities (IDD) and their teachers to help ensure a safe school environment. Additionally, we will understand nationally the perceptions of COVID-19 and identify facilitators and barriers to help with the adoption of testing in other parts of the US and the necessary strategies to address other mitigation strategies including vaccination.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

    Baltimore, Maryland, United States

  • University of Missouri

    Kansas City, Missouri, United States

  • Special School District

    St Louis, Missouri, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Nov 2020
Primary completion
29 Mar 2024
Completion
29 Mar 2024
Last update posted
23 Feb 2026
Registered enrollment
1,143
Registry id
NCT04565509

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.